$0.00210
-0.00280-57.14%
At close: -
$0.00890
0.00680323.81%
After Hours: Apr 4, 4:00 PM EDT
Comments
Loading...
NLS Pharmaceutics Analyst Ratings and Price Targets | NASDAQ:NLSPW | Benzinga
NLS Pharmaceutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for NLS Pharmaceutics Corp from these most-recent analyst ratings.
Analyst Ratings for NLS Pharmaceutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for NLS Pharmaceutics (NLSPW) stock?
There is no price target for NLS Pharmaceutics
What is the most recent analyst rating for NLS Pharmaceutics (NLSPW)?
There is no analyst for NLS Pharmaceutics
When was the last upgrade for NLS Pharmaceutics (NLSPW)?
There is no last upgrade for NLS Pharmaceutics
When was the last downgrade for NLS Pharmaceutics (NLSPW)?
There is no last downgrade for NLS Pharmaceutics.
When is the next analyst rating going to be posted or updated for NLS Pharmaceutics (NLSPW)?
There is no next analyst rating for NLS Pharmaceutics.
Is the Analyst Rating NLS Pharmaceutics (NLSPW) correct?
There is no next analyst rating for NLS Pharmaceutics.
Browse analyst ratings and price targets on all stocks.